详细信息
A reduction-triggered nanocarrier based on host-guest interaction between pillar[5]arene derivative and viologen on MSN for intracellular delivery ( SCI-EXPANDED收录)
文献类型:期刊文献
英文题名:A reduction-triggered nanocarrier based on host-guest interaction between pillar[5]arene derivative and viologen on MSN for intracellular delivery
作者:Xu, Jun;Liu, Yehong;Li, Gaoyang;Peng, Mingxia;Xu, Shouhong[1];Liu, Honglai
机构:[1]East China Univ Sci & Technol, Shanghai Engn Res Ctr Hierarch Nanomat, Key Lab Adv Mat, Shanghai 200237, Peoples R China; East China Univ Sci & Technol, Sch Chem & Mol Engn, Shanghai 200237, Peoples R China
年份:2022
卷号:68
外文期刊名:JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
收录:;WOS:【SCI-EXPANDED(收录号:WOS:000788084100007)】;
基金:Acknowledgement This work was supported by the National Natural Science Foundation of China (No. 22078087 and No. 21776071) . The authors also wish to thank Miss Gangmei Tang for her advice on drawing graphs and Wanshi Tang for help with language.
语种:英文
外文关键词:Intracellular delivery; Mesoporous silica nanoparticles; Host-guest interaction; Controlled drug release
摘要:Due to the difference of intracellular microenvironment between tumour and normal cells, stimuli-responsive supramolecular assemblies have been widely designed for accurate drug delivery and controlled release. This study introduces a reduction-triggered drug delivery system that encapsulates drugs in mesoporous silica nanomaterials (MSNs) pores using a supramolecular nanovalve based on host-guest interactions between pillar [5]arene and viologen groups. PEGylated pillar[5]arene (the host) can encircle viologen stalks (the guest), which have been grafted onto the MSNs surface in advance, and separate from viologen when it encounters a reducing agent. In vitro drug release experiments were conducted under various pH conditions and reducing environments to control drug release. Furthermore, cytotoxicity studies revealed that the drug-loaded nanoparticles exhibited low cytotoxicity to LO2 cells but effectively induced apoptosis in HepG2 cells. This work contributes to the development of targeted intracellular drug delivery in tumour clinical therapy.
参考文献:
正在载入数据...
